India, April 15 -- Stock of Tempus AI, Inc. (TEM) is climbing about 9 percent on Wednesday morning trading after the company, along with Predicta Biosciences, announced the commercial expansion of a co-branded whole-genome sequencing assay, currently known as GenoPredicta.
The company's shares are currently trading at $54.30 on the Nasdaq, up 9.74 percent. The stock opened at $50.35 and has climbed as high as $54.91 so far in today's session. Over the past year, it has traded in a range of $39.01 to $104.32.
GenoPredicta intended for the comprehensive genomic characterization of hematologic malignancies and measurable residual disease monitoring.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Se...